Three Covid vaccine developers report promising initial results from human trials
Two of the vaccine developers — the first, a partnership between Oxford University and British-Swedish drugmaker AstraZeneca; the second, Chinese company CanSino Biologics — published their early results as peer-reviewed studies in The Lancet, a British medical journal.
Source: The Economic Times - Category: Consumer Health News Source Type: news
More News: AstraZeneca | China Health | Health | Oxford University | Partnerships | Study | Sweden Health | UK Health | Vaccines